• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨骼肌肌球蛋白和心肌肌球蛋白的促凝活性依赖于污染的磷脂。

Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid.

机构信息

Department of Research and.

Department of Medicine, VA Boston Healthcare System, Boston, MA; and.

出版信息

Blood. 2020 Nov 19;136(21):2469-2472. doi: 10.1182/blood.2020005930.

DOI:10.1182/blood.2020005930
PMID:32604409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685214/
Abstract

Recent reports indicate that suspended skeletal and cardiac myosin, such as might be released during injury, can act as procoagulants by providing membrane-like support for factors Xa and Va in the prothrombinase complex. Further, skeletal myosin provides membrane-like support for activated protein C. This raises the question of whether purified muscle myosins retain procoagulant phospholipid through purification. We found that lactadherin, a phosphatidyl-l-serine-binding protein, blocked >99% of prothrombinase activity supported by rabbit skeletal and by bovine cardiac myosin. Similarly, annexin A5 and phospholipase A2 blocked >95% of myosin-supported activity, confirming that contaminating phospholipid is required to support myosin-related prothrombinase activity. We asked whether contaminating phospholipid in myosin preparations may also contain tissue factor (TF). Skeletal myosin supported factor VIIa cleavage of factor X equivalent to contamination by ∼1:100 000 TF/myosin, whereas cardiac myosin had TF-like activity >10-fold higher. TF pathway inhibitor inhibited the TF-like activity similar to control TF. These results indicate that purified skeletal muscle and cardiac myosins support the prothrombinase complex indirectly through contaminating phospholipid and also support factor X activation through TF-like activity. Our findings suggest a previously unstudied affinity of skeletal and cardiac myosin for phospholipid membranes.

摘要

最近的报告表明,悬浮的骨骼肌和心肌肌球蛋白,如在损伤过程中释放的肌球蛋白,可通过为凝血酶原酶复合物中的因子 Xa 和 Va 提供类似膜的支持而充当促凝剂。此外,骨骼肌肌球蛋白为活化蛋白 C 提供类似膜的支持。这就提出了一个问题,即纯化的肌肉肌球蛋白在纯化过程中是否保留促凝血磷脂。我们发现,乳贴蛋白,一种与磷脂酰丝氨酸结合的蛋白,可阻断兔骨骼肌和牛心肌肌球蛋白支持的凝血酶原酶活性的>99%。同样, annexin A5 和磷脂酶 A2 阻断了>95%的肌球蛋白支持的活性,证实了污染的磷脂是支持肌球蛋白相关凝血酶原酶活性所必需的。我们想知道肌球蛋白制剂中的污染磷脂是否也可能含有组织因子(TF)。骨骼肌肌球蛋白支持因子 VIIa 对因子 X 的裂解相当于 1:100000 TF/肌球蛋白的污染,而心肌肌球蛋白的 TF 样活性高 10 倍以上。TF 途径抑制剂抑制了与对照 TF 相似的 TF 样活性。这些结果表明,纯化的骨骼肌和心肌肌球蛋白通过污染的磷脂间接支持凝血酶原酶复合物,并且还通过 TF 样活性支持因子 X 的激活。我们的研究结果表明,骨骼肌和心肌肌球蛋白对磷脂膜具有以前未研究过的亲和力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e52/7685214/006db49f548e/bloodBLD2020005930absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e52/7685214/006db49f548e/bloodBLD2020005930absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e52/7685214/006db49f548e/bloodBLD2020005930absf1.jpg

相似文献

1
Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid.骨骼肌肌球蛋白和心肌肌球蛋白的促凝活性依赖于污染的磷脂。
Blood. 2020 Nov 19;136(21):2469-2472. doi: 10.1182/blood.2020005930.
2
Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites.乳黏素通过竞争磷脂结合位点来抑制凝血酶复合物。
Blood. 2003 Apr 1;101(7):2628-36. doi: 10.1182/blood-2002-07-1951. Epub 2002 Nov 27.
3
Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids.骨骼肌和心肌肌球蛋白的促凝血活性既需要肌球蛋白蛋白,也需要与肌球蛋白相关的阴离子磷脂。
Blood. 2021 Apr 1;137(13):1839-1842. doi: 10.1182/blood.2020008580.
4
Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.促凝血球蛋白肌球蛋白上的分子相互作用位点,用于因子 Xa 依赖性凝血酶原激活。
J Biol Chem. 2019 Oct 11;294(41):15176-15181. doi: 10.1074/jbc.AC119.010236. Epub 2019 Sep 3.
5
Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.新型凝血分子:骨骼肌肌球蛋白和心肌肌球蛋白。
J Thromb Haemost. 2021 Jan;19(1):7-19. doi: 10.1111/jth.15097. Epub 2020 Oct 25.
6
Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.蛋白C途径对组织因子诱导的凝血酶生成的抑制机制。与组织因子途径抑制剂联合使用的协同效应。
J Biol Chem. 1997 Mar 21;272(12):7983-94. doi: 10.1074/jbc.272.12.7983.
7
Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.肌球蛋白促进凝血酶生成和体内外凝血。
Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):901-913. doi: 10.1161/ATVBAHA.120.313990. Epub 2020 Feb 27.
8
Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.组织因子抑制物:TFPI 和 TFPI 构建体对因子 VIIa 催化的因子 IX 和因子 X 的激活作用。
J Thromb Haemost. 2014 Nov;12(11):1826-37. doi: 10.1111/jth.12713. Epub 2014 Oct 12.
9
Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.红细胞衍生的微粒支持活化蛋白C介导的血液凝固调节。
PLoS One. 2014 Aug 19;9(8):e104200. doi: 10.1371/journal.pone.0104200. eCollection 2014.
10
Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.磷脂通过底物和产物相互作用调节组织因子/因子VIIa(TF/VIIa)对因子X的激活。
Biochemistry. 2005 Jun 7;44(22):8187-97. doi: 10.1021/bi050338b.

引用本文的文献

1
SkM-ing information from traumatized tissue.从创伤组织中获取骨骼肌信息。
J Thromb Haemost. 2022 Jun;20(6):1306-1308. doi: 10.1111/jth.15721.
2
Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation.骨骼肌肌球蛋白通过其 A3 结构域与因子 XI 结合并增强凝血酶诱导的因子 XI 激活,从而促进凝血。
J Biol Chem. 2022 Feb;298(2):101567. doi: 10.1016/j.jbc.2022.101567. Epub 2022 Jan 7.
3
Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation.

本文引用的文献

1
Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.肌球蛋白促进凝血酶生成和体内外凝血。
Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):901-913. doi: 10.1161/ATVBAHA.120.313990. Epub 2020 Feb 27.
2
Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin.活化蛋白C抗凝活性可被骨骼肌肌球蛋白增强。
Haematologica. 2020 Aug;105(8):e424-e427. doi: 10.3324/haematol.2019.242982. Epub 2019 Dec 19.
3
Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.
磷脂酰丝氨酸是新冠病毒血栓炎症反应中一个被忽视的介质。
Heliyon. 2021 Jan;7(1):e06033. doi: 10.1016/j.heliyon.2021.e06033. Epub 2021 Jan 20.
4
Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids.骨骼肌和心肌肌球蛋白的促凝血活性既需要肌球蛋白蛋白,也需要与肌球蛋白相关的阴离子磷脂。
Blood. 2021 Apr 1;137(13):1839-1842. doi: 10.1182/blood.2020008580.
5
Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.新型凝血分子:骨骼肌肌球蛋白和心肌肌球蛋白。
J Thromb Haemost. 2021 Jan;19(1):7-19. doi: 10.1111/jth.15097. Epub 2020 Oct 25.
促凝血球蛋白肌球蛋白上的分子相互作用位点,用于因子 Xa 依赖性凝血酶原激活。
J Biol Chem. 2019 Oct 11;294(41):15176-15181. doi: 10.1074/jbc.AC119.010236. Epub 2019 Sep 3.
4
Structure of actomyosin rigour complex at 5.2 Å resolution and insights into the ATPase cycle mechanism.肌球蛋白刚性复合物的结构分辨率为 5.2Å 及对 ATP 酶循环机制的深入了解。
Nat Commun. 2017 Jan 9;8:13969. doi: 10.1038/ncomms13969.
5
Mammalian Nonmuscle Myosin II Binds to Anionic Phospholipids with Concomitant Dissociation of the Regulatory Light Chain.哺乳动物非肌肉肌球蛋白II与阴离子磷脂结合并伴随调节轻链解离。
J Biol Chem. 2016 Nov 25;291(48):24828-24837. doi: 10.1074/jbc.M116.739185. Epub 2016 Oct 3.
6
Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.促血栓形成的骨骼肌肌球蛋白通过结合因子Xa和Va直接增强凝血酶原激活。
Blood. 2016 Oct 6;128(14):1870-1878. doi: 10.1182/blood-2016-03-707679. Epub 2016 Jul 15.
7
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.VIII 因子和 V 因子的 C2 结构域中的保守突变改变了磷脂结合和辅因子活性。
Blood. 2012 Aug 30;120(9):1923-32. doi: 10.1182/blood-2012-01-408245. Epub 2012 May 21.
8
Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature.乳黏素选择性地结合含有磷脂酰-L-丝氨酸且曲率增加的膜。
Biochim Biophys Acta. 2004 Nov 17;1667(1):82-90. doi: 10.1016/j.bbamem.2004.09.006.
9
WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.内源性凝血瀑布序列
Science. 1964 Sep 18;145(3638):1310-2. doi: 10.1126/science.145.3638.1310.
10
Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor protein C.维生素K依赖蛋白的制备,如凝血因子II、VII、IX和X以及凝血抑制蛋白C。
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jun 25;790(1-2):183-97. doi: 10.1016/s1570-0232(03)00082-5.